- Home
- KNSA vs WLFC Comparison
KNSA vs WLFC Comparison
Compare KNSA & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- WLFC
- Stock Information
- Founded
- KNSA 2015
- WLFC 1985
- Country
- KNSA United Kingdom
- WLFC United States
- Employees
- KNSA N/A
- WLFC N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- WLFC Industrial Specialties
- Sector
- KNSA Health Care
- WLFC Consumer Discretionary
- Exchange
- KNSA Nasdaq
- WLFC Nasdaq
- Market Cap
- KNSA 1.3B
- WLFC 1.3B
- IPO Year
- KNSA 2018
- WLFC 1996
- Fundamental
- Price
- KNSA $18.73
- WLFC $194.26
- Analyst Decision
- KNSA Strong Buy
- WLFC
- Analyst Count
- KNSA 5
- WLFC 0
- Target Price
- KNSA $36.60
- WLFC N/A
- AVG Volume (30 Days)
- KNSA 469.7K
- WLFC 39.7K
- Earning Date
- KNSA 02-26-2025
- WLFC 03-12-2025
- Dividend Yield
- KNSA N/A
- WLFC 0.64%
- EPS Growth
- KNSA N/A
- WLFC 113.10
- EPS
- KNSA N/A
- WLFC 14.15
- Revenue
- KNSA $384,098,000.00
- WLFC $520,429,000.00
- Revenue This Year
- KNSA $60.05
- WLFC N/A
- Revenue Next Year
- KNSA $36.74
- WLFC N/A
- P/E Ratio
- KNSA N/A
- WLFC $13.99
- Revenue Growth
- KNSA 54.41
- WLFC 35.45
- 52 Week Low
- KNSA $16.56
- WLFC $46.20
- 52 Week High
- KNSA $28.15
- WLFC $235.43
- Technical
- Relative Strength Index (RSI)
- KNSA 38.56
- WLFC 41.17
- Support Level
- KNSA $18.27
- WLFC $192.03
- Resistance Level
- KNSA $19.05
- WLFC $229.67
- Average True Range (ATR)
- KNSA 0.61
- WLFC 12.53
- MACD
- KNSA -0.05
- WLFC -2.12
- Stochastic Oscillator
- KNSA 34.42
- WLFC 5.92
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About WLFC Willis Lease Finance Corporation
Willis Lease Finance Corp with its subsidiaries is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments namely Leasing and Related Operations which involves acquiring and leasing, pursuant to operating leases, commercial aircraft, aircraft engines and other aircraft equipment and the selective purchase and resale of commercial aircraft engines and other aircraft equipment and other related businesses and Spare Parts Sales segment involves the purchase and resale of after-market engine parts, whole engines, engine modules and portable aircraft components. The company generates the majority of its revenue from leasing and related operations.